Artwork

Innhold levert av VJOncology. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av VJOncology eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Highlights at AACR 2023: mRNA vaccines in melanoma and novel RAF inhibitors

18:46
 
Del
 

Manage episode 374905000 series 2424442
Innhold levert av VJOncology. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av VJOncology eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

In this podcast, we’ll be covering highlights from the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL, including personalized mRNA and neoantigen vaccines, nivolumab with the standard of care in prostate cancer, and BGB-3245, a novel RAF dimer inhibitor, in solid tumors. Hear from Jeffrey Weber, NYU Langone Perlmutter Cancer Center, NY, Mansi Saxena, Icahn School of Medicine at Mount Sinai, New York, NY, John Michael Bryant, Moffitt Cancer Center, Tampa, FL, and Alison Schram, Memorial Sloan Kettering Cancer Center, New York, NY, who will all talk on these exciting advances.

The post Highlights at AACR 2023: mRNA vaccines in melanoma and novel RAF inhibitors appeared first on VJOncology.

  continue reading

180 episoder

Artwork
iconDel
 
Manage episode 374905000 series 2424442
Innhold levert av VJOncology. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av VJOncology eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

In this podcast, we’ll be covering highlights from the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL, including personalized mRNA and neoantigen vaccines, nivolumab with the standard of care in prostate cancer, and BGB-3245, a novel RAF dimer inhibitor, in solid tumors. Hear from Jeffrey Weber, NYU Langone Perlmutter Cancer Center, NY, Mansi Saxena, Icahn School of Medicine at Mount Sinai, New York, NY, John Michael Bryant, Moffitt Cancer Center, Tampa, FL, and Alison Schram, Memorial Sloan Kettering Cancer Center, New York, NY, who will all talk on these exciting advances.

The post Highlights at AACR 2023: mRNA vaccines in melanoma and novel RAF inhibitors appeared first on VJOncology.

  continue reading

180 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett